As of Thursday, April 2, the Moon phase is North America is Waning Gibbous, according to NASA's Daily Moon Guide.
Immunovant’s first-generation FcRn inhibitor flunked a pair of phase 3 eye disease trials, appearing to end the last hopes of ...
Alkermes announced today the initiation of the Brilliance Studies, a phase 3 program that will test the safety and efficacy ...
A proof-of-concept study supports the safety and efficacy of rezpegaldesleukin vs placebo for treating severe-to-very-severe ...
Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results
Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including ...
The Last-Minute Sales Phase opens on 1 April 2026 at 11:00 am (Eastern Time) / 8:00 am (Pacific Time) / 9:00 am (Mexico City ...
In Phase One of this series, I focused on how entrepreneurs and founders can use AI as a thought partner to challenge assumptions, sharpen market understanding and validate problems before they even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results